EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing Tumor Immunotherapy by Multivalent Anti‐PD‐L1 Nanobody Assembled via Ferritin Nanocage

Manman Liu, Duo Jin, Wenxin Yu, Jiaji Yu, Kaiming Cao, Junjie Cheng, Xiaohu Zheng, Andrew Wang, Yangzhong Liu iD

Advanced Science · 2024

DOI: 10.1002/advs.202308248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Manman Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Department of Chemistry, University of Science…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Ferritins, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Plans for Major Provincial Science & Technology Projects, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasing immunotherapy response rate and durability can lead to significant improvements in cancer care. To address this challenge, a novel multivalent immune checkpoint therapeutic platform is constructed through site‐specific ligation of anti‐PD‐L1 nanobody (Nb) on ferritin (Ftn) nanocage. Nb‐Ftn blocks PD‐1/PD‐L1 interaction and downregulates PD‐L1 levels via endocytosis‐induced degradation. In addition, the cage structure of Ftn allows encapsulation of indocyanine green (ICG), an FDA‐approved dye. Photothermal treatment with Nb‐Ftn@ICG induces immunogenic death of tumor cells, which improves systemic immune response via maturation of dendritic cells and enhanced infiltration of T cells. Moreover, Nb‐Ftn encapsulation significantly enhances cellular uptake, tumor accumulation and retention of ICG. In vivo assays showed that this nanoplatform ablates the primary tumor, suppresses abscopal tumors and inhibits tumor metastasis, leading to a prolonged survival rate. This work presents a novel strategy for improving cancer immunotherapy using multivalent nanobody‐ferritin conjugates as immunological targeting and enhancing carriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenFerritinsImmunotherapyNeoplasmsSingle-Domain AntibodiesAnimalsHumansMiceCell Line, TumorDisease Models, AnimalIndocyanine Green

Stichwörter der Autor:innen

PD‐L1ferritinimmunotherapymultivalent nanobody

Substanzen

B7-H1 AntigenCD274 protein, humanFerritinsIndocyanine GreenSingle-Domain Antibodies

Autor:innen und Institutionen

  • Department of Pharmacy, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Department of Chemistry, University of Science and Technology of China, Hefei, 230001, China.
  • The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University o…
  • Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, 75230, USA.

ORCID-Profile: Yangzhong Liu

Förderung

  • National Key R&D Program of China
  • Plans for Major Provincial Science & Technology Projects
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Liu, M., Jin, D., Yu, W., Yu, J., Cao, K., Cheng, J., Zheng, X., Wang, A., & Liu, Y. (2024). Enhancing Tumor Immunotherapy by Multivalent Anti‐PD‐L1 Nanobody Assembled via Ferritin Nanocage. Advanced Science. https://doi.org/10.1002/advs.202308248

Vancouver

Liu M, Jin D, Yu W, Yu J, Cao K, Cheng J, et al. Enhancing Tumor Immunotherapy by Multivalent Anti‐PD‐L1 Nanobody Assembled via Ferritin Nanocage. Advanced Science. 2024. doi:10.1002/advs.202308248

BibTeX
@article{Liu2024,
  author = {Liu, Manman and Jin, Duo and Yu, Wenxin and Yu, Jiaji and Cao, Kaiming and Cheng, Junjie and Zheng, Xiaohu and Wang, Andrew and Liu, Yangzhong},
  title = {Enhancing Tumor Immunotherapy by Multivalent Anti‐PD‐L1 Nanobody Assembled via Ferritin Nanocage},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202308248}
}
Kostenlos starten →